ZINC GLUCONATE

ZINC GLUCONATE was reported 26686 times

ZINC GLUCONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 54 0.7714
1 RADIATION INFLAMMATION 28 0.3500
2 COPPER DEFICIENCY 22 0.1833
3 SEDATION COMPLICATION 316 0.1237
4 PRODUCT ADMINISTRATION ISSUE 21 0.1005
5 RHINOCEREBRAL MUCORMYCOSIS 30 0.0865
6 MULTIPLE DRUG THERAPY 61 0.0809
7 CREATININE RENAL CLEARANCE DECREASED 323 0.0806
8 CARBUNCLE 21 0.0742
9 APPENDICOLITH 27 0.0698
10 CREATININE RENAL CLEARANCE INCREASED 51 0.0682
11 NECROSIS ISCHAEMIC 21 0.0456
12 PULMONARY PAIN 110 0.0376
13 BLOOD CALCIUM DECREASED 360 0.0320
14 SINUSITIS FUNGAL 25 0.0312
15 GENITAL ULCERATION 22 0.0286
16 FACET JOINT SYNDROME 93 0.0285
17 MONOCLONAL IMMUNOGLOBULIN PRESENT 21 0.0276
18 PERIPHERAL VENOUS DISEASE 112 0.0274
19 ONYCHOMYCOSIS 116 0.0264
20 INFUSION SITE DISCHARGE 43 0.0245
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
22 ONYCHOMADESIS 96 0.0229
23 RHEUMATIC FEVER 100 0.0224
24 FINGER DEFORMITY 108 0.0223
25 ORTHOSTATIC HYPOTENSION 360 0.0207
26 PNEUMONIA STREPTOCOCCAL 22 0.0201
27 FEMALE GENITAL TRACT FISTULA 33 0.0193
28 HYPOTHALAMO-PITUITARY DISORDER 27 0.0185
29 CONGENITAL ANOMALY 143 0.0185
30 RENAL FUNCTION TEST ABNORMAL 85 0.0183
31 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 23 0.0183
32 MACROCYTOSIS 21 0.0181
33 SINUS PAIN 41 0.0176
34 PRODUCT LABEL CONFUSION 97 0.0166
35 GENITAL PAIN 24 0.0162
36 INFUSION SITE BRUISING 35 0.0162
37 BLEPHAROSPASM 98 0.0155
38 BREAST CANCER STAGE III 91 0.0140
39 NAIL DISORDER 122 0.0139
40 SEDATION 351 0.0134
41 MUSCLE INJURY 111 0.0134
42 SPUTUM INCREASED 28 0.0129
43 NASAL POLYPS 63 0.0128
44 SEASONAL ALLERGY 180 0.0127
45 HAEMORRHAGIC DIATHESIS 45 0.0126
46 C-REACTIVE PROTEIN ABNORMAL 81 0.0126
47 INFUSION SITE HAEMORRHAGE 41 0.0125
48 EYELID PAIN 25 0.0123
49 ENDOMETRIAL CANCER 27 0.0123
50 INFUSION SITE PRURITUS 38 0.0120
51 WOUND INFECTION 131 0.0120
52 EAR CONGESTION 32 0.0118
53 WOUND SECRETION 45 0.0115
54 GRIP STRENGTH DECREASED 100 0.0114
55 OBESITY 181 0.0113
56 LIP DRY 103 0.0113
57 RESPIRATORY SYMPTOM 32 0.0112
58 BLADDER SPASM 21 0.0112
59 CHRONIC SINUSITIS 42 0.0112
60 HYPERCHOLESTEROLAEMIA 108 0.0112
61 PARANASAL SINUS DISCOMFORT 42 0.0111
62 DIASTOLIC DYSFUNCTION 34 0.0110
63 TASTE DISORDER 222 0.0109
64 HYPERPHOSPHATAEMIA 23 0.0107
65 BACK INJURY 116 0.0107
66 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 76 0.0106
67 HELICOBACTER INFECTION 109 0.0106
68 ARTHRITIS INFECTIVE 48 0.0103
69 APLASTIC ANAEMIA 54 0.0103
70 DUODENAL ULCER PERFORATION 76 0.0102
71 LIVE BIRTH 83 0.0099
72 JOINT RANGE OF MOTION DECREASED 133 0.0099
73 COGNITIVE DISORDER 463 0.0099
74 SKIN ATROPHY 57 0.0099
75 LIMB MASS 21 0.0096
76 BLOOD PHOSPHORUS INCREASED 26 0.0095
77 NEUROLOGICAL DECOMPENSATION 22 0.0095
78 MULTIPLE ALLERGIES 74 0.0094
79 BURSITIS 114 0.0094
80 WOUND COMPLICATION 32 0.0093
81 COELIAC DISEASE 91 0.0093
82 INFUSION SITE SWELLING 58 0.0092
83 DEPRESSED LEVEL OF CONSCIOUSNESS 360 0.0091
84 FOLLICULITIS 95 0.0091
85 SKIN LACERATION 97 0.0089
86 APPETITE DISORDER 59 0.0089
87 MOBILITY DECREASED 632 0.0088
88 SPINAL STENOSIS 36 0.0087
89 SKIN WARM 50 0.0086
90 FIBROSIS 26 0.0084
91 LUNG OPACITY 22 0.0083
92 AORTIC STENOSIS 29 0.0083
93 OSTEOARTHRITIS 345 0.0081
94 INFUSION SITE REACTION 24 0.0080
95 FOOD POISONING 43 0.0080
96 BRAIN FOG 125 0.0080
97 BONE EROSION 28 0.0079
98 INFUSION SITE PAIN 102 0.0079
99 SKIN ODOUR ABNORMAL 31 0.0079
100 ABDOMINAL MASS 21 0.0078
101 AMMONIA INCREASED 40 0.0078
102 BALANCE DISORDER 671 0.0078
103 SKIN PAPILLOMA 31 0.0077
104 IRRITABLE BOWEL SYNDROME 165 0.0077
105 VITAMIN B12 DECREASED 22 0.0076
106 EYELID MARGIN CRUSTING 22 0.0076
107 SUSPECTED COVID-19 25 0.0076
108 ABNORMAL FAECES 62 0.0076
109 PRODUCT ADMINISTRATION INTERRUPTED 59 0.0075
110 VASCULAR DEVICE INFECTION 34 0.0075
111 TENDERNESS 78 0.0075
112 HAND DEFORMITY 98 0.0075
113 PEMPHIGUS 93 0.0074
114 IRON DEFICIENCY 33 0.0073
115 PARANASAL SINUS HYPERSECRETION 28 0.0073
116 BLOOD URIC ACID INCREASED 42 0.0073
117 INSURANCE ISSUE 111 0.0073
118 BLADDER PAIN 23 0.0072
119 FIBROMYALGIA 176 0.0072
120 INFUSION SITE ERYTHEMA 61 0.0072
121 RALES 42 0.0072
122 SYNOVITIS 130 0.0072
123 WOUND 201 0.0072
124 EPIGASTRIC DISCOMFORT 28 0.0072
125 URINE ODOUR ABNORMAL 42 0.0071
126 PROSTATOMEGALY 28 0.0071
127 VULVOVAGINAL DRYNESS 23 0.0071
128 BODY HEIGHT DECREASED 76 0.0071
129 TUMOUR MARKER INCREASED 34 0.0071
130 LOWER RESPIRATORY TRACT INFECTION 314 0.0069
131 EAR PAIN 134 0.0069
132 OVERWEIGHT 37 0.0069
133 SINUS DISORDER 135 0.0068
134 NIGHT SWEATS 218 0.0068
135 PRE-EXISTING CONDITION IMPROVED 42 0.0067
136 HIDRADENITIS 61 0.0067
137 POLYMYALGIA RHEUMATICA 21 0.0066
138 KNEE ARTHROPLASTY 139 0.0066
139 BRONCHIECTASIS 44 0.0065
140 SCIATICA 104 0.0065
141 LIVER FUNCTION TEST INCREASED 140 0.0065
142 HYPOPHOSPHATAEMIA 48 0.0065
143 INTERVERTEBRAL DISC DEGENERATION 60 0.0065
144 ANAL INCONTINENCE 58 0.0064
145 ADVERSE REACTION 85 0.0064
146 URINE ABNORMALITY 29 0.0064
147 DYSPHORIA 32 0.0063
148 MYASTHENIA GRAVIS 51 0.0063
149 UPPER-AIRWAY COUGH SYNDROME 52 0.0063
150 GAIT INABILITY 210 0.0063
151 ROSACEA 29 0.0062
152 GLOSSITIS 22 0.0062
153 PERICARDITIS 103 0.0061
154 DYSLIPIDAEMIA 31 0.0061
155 HIATUS HERNIA 79 0.0061
156 ARTHROPATHY 339 0.0061
157 PAROSMIA 46 0.0061
158 LYMPHOEDEMA 42 0.0061
159 PHOTOPHOBIA 114 0.0061
160 HEPATIC ENZYME ABNORMAL 30 0.0060
161 HORDEOLUM 26 0.0060
162 ORAL CANDIDIASIS 79 0.0060
163 SARS-COV-2 TEST POSITIVE 79 0.0060
164 BLOOD IRON DECREASED 70 0.0059
165 SINUSITIS 601 0.0059
166 AUTOIMMUNE THYROIDITIS 22 0.0058
167 ORAL PAIN 130 0.0058
168 COVID-19 1002 0.0057
169 SENSITIVE SKIN 42 0.0057
170 MENISCUS INJURY 35 0.0057
171 BLOOD MAGNESIUM DECREASED 49 0.0057
172 DIZZINESS POSTURAL 55 0.0057
173 RENAL CYST 45 0.0057
174 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
175 DERMATITIS CONTACT 64 0.0056
176 NECK PAIN 313 0.0056
177 LIMB INJURY 152 0.0056
178 EXOSTOSIS 51 0.0056
179 SPINAL OSTEOARTHRITIS 49 0.0056
180 BLOOD CHOLESTEROL INCREASED 260 0.0056
181 IRON DEFICIENCY ANAEMIA 51 0.0055
182 NORMAL NEWBORN 30 0.0055
183 CANDIDA INFECTION 93 0.0055
184 HYPOAESTHESIA ORAL 83 0.0055
185 BLOOD CALCIUM INCREASED 48 0.0055
186 ATTENTION DEFICIT HYPERACTIVITY DISORDER 23 0.0055
187 OESOPHAGEAL DISORDER 21 0.0054
188 IMPAIRED HEALING 179 0.0054
189 FUNGAL SKIN INFECTION 22 0.0054
190 MACULAR DEGENERATION 65 0.0054
191 FOOD ALLERGY 42 0.0054
192 SNEEZING 122 0.0054
193 TENDON PAIN 41 0.0054
194 GLOSSODYNIA 121 0.0054
195 FULL BLOOD COUNT ABNORMAL 57 0.0054
196 LIVER INJURY 132 0.0054
197 ORAL INFECTION 21 0.0054
198 CONSTIPATION 1168 0.0054
199 BLADDER DISORDER 53 0.0053
200 COVID-19 PNEUMONIA 63 0.0053
201 WEIGHT FLUCTUATION 55 0.0053
202 FULL BLOOD COUNT DECREASED 105 0.0052
203 HERPES VIRUS INFECTION 30 0.0052
204 MUSCLE STRAIN 45 0.0052
205 TONGUE DISCOMFORT 22 0.0052
206 SINUS CONGESTION 70 0.0052
207 GASTROINTESTINAL PAIN 57 0.0052
208 MICTURITION URGENCY 59 0.0052
209 NEURALGIA 125 0.0051
210 RESPIRATORY TRACT CONGESTION 81 0.0051
211 SWELLING OF EYELID 32 0.0051
212 WHEEZING 302 0.0051
213 PARAESTHESIA ORAL 73 0.0051
214 FOOT DEFORMITY 56 0.0050
215 HAEMOGLOBIN INCREASED 23 0.0050
216 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 242 0.0050
217 EAR DISORDER 23 0.0050
218 DYSSTASIA 146 0.0050
219 LIGAMENT RUPTURE 22 0.0050
220 HOT FLUSH 374 0.0050
221 WHEELCHAIR USER 22 0.0049
222 CARPAL TUNNEL SYNDROME 69 0.0049
223 VITAMIN D DEFICIENCY 48 0.0049
224 PSEUDOMONAS INFECTION 42 0.0049
225 SLEEP DISORDER 345 0.0049
226 EXERCISE TOLERANCE DECREASED 28 0.0049
227 DRY MOUTH 393 0.0048
228 JOINT STIFFNESS 127 0.0048
229 PSORIATIC ARTHROPATHY 196 0.0048
230 HEPATIC ENCEPHALOPATHY 45 0.0048
231 INFLAMMATION 248 0.0048
232 POST PROCEDURAL INFECTION 39 0.0048
233 STOMATITIS 290 0.0048
234 PERIORBITAL SWELLING 27 0.0048
235 OBSTRUCTIVE AIRWAYS DISORDER 53 0.0048
236 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 24 0.0047
237 THINKING ABNORMAL 88 0.0047
238 GASTROOESOPHAGEAL REFLUX DISEASE 379 0.0047
239 BLISTER 264 0.0047
240 BLOOD TESTOSTERONE DECREASED 32 0.0047
241 TYPE 2 DIABETES MELLITUS 157 0.0047
242 SLEEP APNOEA SYNDROME 89 0.0047
243 DECUBITUS ULCER 38 0.0047
244 HYPERVOLAEMIA 23 0.0046
245 GASTROENTERITIS VIRAL 84 0.0046
246 SECRETION DISCHARGE 58 0.0046
247 FAILURE TO THRIVE 24 0.0046
248 APPENDICITIS 43 0.0046
249 BLOOD POTASSIUM DECREASED 138 0.0046
250 GOUT 82 0.0046
251 MUSCULOSKELETAL STIFFNESS 400 0.0046
252 ABDOMINAL DISTENSION 476 0.0046
253 BLOOD TEST ABNORMAL 64 0.0046
254 LIGAMENT SPRAIN 45 0.0045
255 WALKING AID USER 30 0.0045
256 JOINT INJURY 97 0.0045
257 FAECES SOFT 33 0.0045
258 SPINAL PAIN 53 0.0045
259 SYMPTOM RECURRENCE 27 0.0045
260 WRIST FRACTURE 54 0.0045
261 PRODUCTIVE COUGH 213 0.0045
262 INCREASED TENDENCY TO BRUISE 41 0.0045
263 NOCTURIA 54 0.0044
264 VITAMIN D DECREASED 38 0.0044
265 EYE INFECTION 50 0.0044
266 RHINORRHOEA 285 0.0044
267 PERIPHERAL SWELLING 677 0.0044
268 LUNG DISORDER 215 0.0044
269 JAW DISORDER 24 0.0044
270 UPPER RESPIRATORY TRACT INFECTION 202 0.0044
271 POLYARTHRITIS 23 0.0044
272 DIVERTICULUM 31 0.0044
273 EMPHYSEMA 44 0.0044
274 HEAD DISCOMFORT 77 0.0043
275 CARDIAC FLUTTER 28 0.0043
276 MIGRAINE 413 0.0043
277 EYE PAIN 244 0.0043
278 SCAR 74 0.0043
279 PRODUCT DISTRIBUTION ISSUE 40 0.0043
280 PROCEDURAL COMPLICATION 33 0.0043
281 RED BLOOD CELL COUNT DECREASED 123 0.0043
282 DYSPNOEA EXERTIONAL 162 0.0043
283 PERIPHERAL COLDNESS 59 0.0043
284 POLLAKIURIA 179 0.0043
285 BRONCHITIS 317 0.0043
286 ILLNESS 439 0.0043
287 THIRST 76 0.0042
288 PNEUMONIA BACTERIAL 39 0.0042
289 DIABETIC NEUROPATHY 21 0.0042
290 RESTLESS LEGS SYNDROME 77 0.0042
291 POOR QUALITY SLEEP 91 0.0042
292 URINARY TRACT INFECTION 719 0.0042
293 INFUSION RELATED REACTION 279 0.0042
294 EAR INFECTION 112 0.0042
295 SCAB 48 0.0042
296 OROPHARYNGEAL DISCOMFORT 38 0.0042
297 TROPONIN INCREASED 32 0.0042
298 MALNUTRITION 47 0.0042
299 MUSCLE SPASMS 770 0.0042
300 EAR DISCOMFORT 43 0.0042
301 OCULAR DISCOMFORT 47 0.0042
302 THERAPEUTIC PRODUCT EFFECT DECREASED 187 0.0042
303 SKIN DISORDER 139 0.0042
304 FEELING COLD 116 0.0042
305 NASAL DRYNESS 26 0.0041
306 GINGIVAL PAIN 33 0.0041
307 SKIN FISSURES 81 0.0041
308 MUSCULAR WEAKNESS 470 0.0041
309 CONTUSION 398 0.0041
310 PRODUCT DOSE OMISSION IN ERROR 117 0.0041
311 BACTERIAL INFECTION 77 0.0041
312 SYSTEMIC LUPUS ERYTHEMATOSUS 145 0.0041
313 RETCHING 87 0.0041
314 THROAT IRRITATION 183 0.0041
315 DECREASED INTEREST 24 0.0041
316 PURPURA 36 0.0041
317 PRODUCT USE COMPLAINT 64 0.0041
318 FLATULENCE 230 0.0041
319 ARTHROPOD BITE 30 0.0040
320 BOWEL MOVEMENT IRREGULARITY 31 0.0040
321 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 22 0.0040
322 SINUS HEADACHE 24 0.0040
323 FUNGAL INFECTION 134 0.0040
324 HYPERAESTHESIA 33 0.0040
325 MUSCULOSKELETAL CHEST PAIN 62 0.0040
326 APHTHOUS ULCER 31 0.0040
327 INITIAL INSOMNIA 41 0.0040
328 ORAL HERPES 78 0.0040
329 RESPIRATORY TRACT INFECTION 104 0.0040
330 NASOPHARYNGITIS 736 0.0040
331 PHARYNGEAL SWELLING 39 0.0040
332 OXYGEN SATURATION DECREASED 224 0.0040
333 DYSPEPSIA 392 0.0040
334 ERUCTATION 77 0.0040
335 THERAPY CHANGE 39 0.0040
336 IMPAIRED QUALITY OF LIFE 57 0.0040
337 RENAL PAIN 42 0.0040
338 MUSCULOSKELETAL DISCOMFORT 68 0.0039
339 HEART RATE ABNORMAL 22 0.0039
340 FALL 1311 0.0039
341 HEPATIC ENZYME INCREASED 268 0.0039
342 AGEUSIA 98 0.0039
343 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
344 FACIAL PAIN 35 0.0039
345 SPUTUM DISCOLOURED 37 0.0039
346 BRUXISM 21 0.0039
347 THYROID DISORDER 60 0.0039
348 GLUCOSE TOLERANCE IMPAIRED 23 0.0039
349 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 66 0.0039
350 HIP SURGERY 21 0.0039
351 TENDONITIS 60 0.0039
352 ANOSMIA 56 0.0039
353 NASAL CONGESTION 227 0.0039
354 UTERINE LEIOMYOMA 28 0.0038
355 MUSCLE SPASTICITY 47 0.0038
356 TRANSFUSION 40 0.0038
357 NEUROPATHY PERIPHERAL 363 0.0038
358 ABDOMINAL DISCOMFORT 640 0.0038
359 OROPHARYNGEAL PAIN 353 0.0038
360 BACK DISORDER 62 0.0038
361 SQUAMOUS CELL CARCINOMA OF SKIN 23 0.0038
362 PYELONEPHRITIS 33 0.0038
363 MEMORY IMPAIRMENT 523 0.0038
364 COUGH 1067 0.0038
365 PRODUCT FORMULATION ISSUE 25 0.0038
366 MUSCLE ATROPHY 48 0.0038
367 ONYCHOCLASIS 26 0.0038
368 ALOPECIA 741 0.0038
369 FOREIGN BODY SENSATION IN EYES 24 0.0038
370 HEART RATE IRREGULAR 85 0.0038
371 HEPATIC STEATOSIS 70 0.0038
372 VIRAL INFECTION 125 0.0038
373 HEPATITIS 96 0.0037
374 URINARY INCONTINENCE 111 0.0037
375 FLANK PAIN 35 0.0037
376 SLUGGISHNESS 38 0.0037
377 BODY TEMPERATURE INCREASED 76 0.0037
378 PELVIC FRACTURE 29 0.0037
379 BLOOD SODIUM DECREASED 70 0.0037
380 SCOLIOSIS 23 0.0037
381 SKIN HAEMORRHAGE 55 0.0037
382 MUSCLE TIGHTNESS 60 0.0037
383 SALIVARY HYPERSECRETION 37 0.0037
384 FEEDING DISORDER 75 0.0037
385 SWELLING 346 0.0037
386 OSTEOPOROSIS 152 0.0037
387 HYPOAESTHESIA 552 0.0037
388 SENSATION OF FOREIGN BODY 31 0.0037
389 DRY EYE 183 0.0037
390 FREQUENT BOWEL MOVEMENTS 99 0.0037
391 EPILEPSY 112 0.0037
392 ROTATOR CUFF SYNDROME 47 0.0037
393 PSYCHIATRIC SYMPTOM 27 0.0037
394 INTENTIONAL DOSE OMISSION 104 0.0036
395 MIDDLE INSOMNIA 68 0.0036
396 FATIGUE 2835 0.0036
397 TOOTH INFECTION 48 0.0036
398 BLOOD PRESSURE SYSTOLIC INCREASED 71 0.0036
399 DISEASE RECURRENCE 173 0.0036
400 PARAESTHESIA 569 0.0036
401 DENTAL CARIES 40 0.0036
402 DECREASED ACTIVITY 39 0.0036
403 MUSCULOSKELETAL PAIN 189 0.0036
404 C-REACTIVE PROTEIN INCREASED 131 0.0036
405 CHEST DISCOMFORT 367 0.0036
406 BLOOD URINE PRESENT 68 0.0036
407 JOINT SWELLING 432 0.0036
408 HAEMOGLOBIN ABNORMAL 23 0.0036
409 INSOMNIA 952 0.0036
410 MUSCULOSKELETAL DISORDER 68 0.0036
411 DEFAECATION URGENCY 25 0.0036
412 PAIN IN JAW 101 0.0036
413 BLOOD PRESSURE INCREASED 545 0.0036
414 VITREOUS FLOATERS 35 0.0036
415 DYSURIA 131 0.0036
416 ORAL DISORDER 26 0.0035
417 ASTHENIA 1330 0.0035
418 INFUSION SITE EXTRAVASATION 22 0.0035
419 NASAL DISCOMFORT 28 0.0035
420 PLATELET COUNT INCREASED 46 0.0035
421 BASAL CELL CARCINOMA 55 0.0035
422 BACK PAIN 819 0.0035
423 CHILLS 413 0.0035
424 PHARYNGITIS STREPTOCOCCAL 38 0.0035
425 ATRIAL FLUTTER 28 0.0035
426 GASTROINTESTINAL DISORDER 314 0.0035
427 CONTRAINDICATED PRODUCT ADMINISTERED 106 0.0035
428 CELLULITIS 176 0.0035
429 TEMPERATURE INTOLERANCE 36 0.0035
430 CORONAVIRUS INFECTION 23 0.0035
431 SKIN INFECTION 39 0.0035
432 DYSPHONIA 203 0.0035
433 HAIR GROWTH ABNORMAL 24 0.0035
434 ULCER 55 0.0035
435 CONJUNCTIVITIS 64 0.0034
436 PRODUCT DOSE OMISSION ISSUE 1014 0.0034
437 NODULE 45 0.0034
438 DRY THROAT 35 0.0034
439 HOSPICE CARE 34 0.0034
440 APHONIA 48 0.0034
441 HYPOTENSION 688 0.0034
442 NEPHROPATHY 32 0.0034
443 INABILITY TO AFFORD MEDICATION 34 0.0034
444 ARTHRALGIA 1423 0.0034
445 IMMUNODEFICIENCY 51 0.0034
446 HYPERSOMNIA 98 0.0034
447 TINNITUS 157 0.0034
448 IMMUNE SYSTEM DISORDER 45 0.0034
449 DRUG-INDUCED LIVER INJURY 107 0.0034
450 ULCER HAEMORRHAGE 23 0.0034
451 TRICUSPID VALVE INCOMPETENCE 27 0.0034
452 CYSTITIS 108 0.0034
453 GAIT DISTURBANCE 648 0.0034
454 AUTOIMMUNE DISORDER 33 0.0034
455 WHITE BLOOD CELL COUNT DECREASED 366 0.0034
456 PRODUCT SUPPLY ISSUE 24 0.0034
457 NERVE COMPRESSION 31 0.0034
458 INTENTIONAL PRODUCT USE ISSUE 294 0.0034
459 FRUSTRATION TOLERANCE DECREASED 27 0.0033
460 SPLENOMEGALY 39 0.0033
461 DYSGEUSIA 247 0.0033
462 BONE PAIN 194 0.0033
463 INCONTINENCE 35 0.0033
464 LACRIMATION INCREASED 100 0.0033
465 SENSORY DISTURBANCE 53 0.0033
466 OEDEMA 179 0.0033
467 PAIN 2026 0.0033
468 POLYURIA 27 0.0033
469 DRUG INTOLERANCE 318 0.0033
470 HICCUPS 27 0.0033
471 TOOTH DISORDER 73 0.0033
472 PRODUCT SUBSTITUTION ISSUE 189 0.0033
473 SKIN LESION 90 0.0033
474 NEPHROLITHIASIS 150 0.0033
475 HYPERLIPIDAEMIA 39 0.0033
476 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
477 BODY TEMPERATURE DECREASED 32 0.0032
478 NERVE INJURY 36 0.0032
479 BURNING SENSATION 227 0.0032
480 HYSTERECTOMY 28 0.0032
481 FEELING DRUNK 24 0.0032
482 BLOOD PRESSURE ABNORMAL 64 0.0032
483 ARTHRITIS 253 0.0032
484 HAIR TEXTURE ABNORMAL 43 0.0032
485 RIB FRACTURE 66 0.0032
486 MOVEMENT DISORDER 103 0.0032
487 PRODUCT AVAILABILITY ISSUE 73 0.0032
488 FLUID RETENTION 163 0.0032
489 TOOTHACHE 58 0.0032
490 BEDRIDDEN 42 0.0032
491 WEIGHT DECREASED 891 0.0032
492 FEELING HOT 195 0.0032
493 HEART RATE INCREASED 315 0.0032
494 HAEMATOCRIT DECREASED 63 0.0032
495 PAIN IN EXTREMITY 935 0.0032
496 HYPOKINESIA 46 0.0032
497 SPINAL DISORDER 30 0.0032
498 HERNIA 61 0.0032
499 VENTRICULAR FIBRILLATION 35 0.0031
500 LOCALISED INFECTION 76 0.0031
501 MYALGIA 534 0.0031
502 DIARRHOEA 2021 0.0031
503 EPISTAXIS 234 0.0031
504 POST PROCEDURAL COMPLICATION 60 0.0031
505 GASTROINTESTINAL INFECTION 28 0.0031
506 INTERVERTEBRAL DISC PROTRUSION 68 0.0031
507 DERMATITIS 65 0.0031
508 CONCUSSION 24 0.0031
509 EYE DISCHARGE 32 0.0031
510 LYMPHADENOPATHY 109 0.0031
511 WEIGHT INCREASED 689 0.0031
512 HEADACHE 1929 0.0031
513 ABSCESS 49 0.0031
514 PRODUCT ADMINISTRATION ERROR 62 0.0031
515 DIVERTICULITIS 85 0.0031
516 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 160 0.0031
517 GASTROINTESTINAL INFLAMMATION 24 0.0031
518 FEELING ABNORMAL 734 0.0031
519 HERPES ZOSTER 176 0.0031
520 IMMUNOSUPPRESSION 27 0.0031
521 ILL-DEFINED DISORDER 185 0.0030
522 INFLUENZA 338 0.0030
523 CHROMATURIA 68 0.0030
524 HYPOPHAGIA 77 0.0030
525 THERAPY CESSATION 154 0.0030
526 BLOOD PRESSURE FLUCTUATION 72 0.0030
527 SKIN EXFOLIATION 253 0.0030
528 DECREASED APPETITE 696 0.0030
529 POOR VENOUS ACCESS 31 0.0030
530 TOOTH FRACTURE 33 0.0030
531 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
532 QUALITY OF LIFE DECREASED 40 0.0030
533 RHINITIS 24 0.0030
534 ARTERIOSCLEROSIS 28 0.0030
535 THERAPY INTERRUPTED 212 0.0030
536 MUSCLE DISORDER 24 0.0030
537 PULMONARY CONGESTION 39 0.0030
538 OCULAR HYPERAEMIA 140 0.0029
539 TOOTH ABSCESS 30 0.0029
540 ABDOMINAL PAIN UPPER 606 0.0029
541 SKIN DISCOLOURATION 135 0.0029
542 CARDIOGENIC SHOCK 42 0.0029
543 HEPATIC CIRRHOSIS 55 0.0029
544 SMALL INTESTINAL OBSTRUCTION 36 0.0029
545 ACUTE RESPIRATORY FAILURE 56 0.0029
546 HEAD INJURY 92 0.0029
547 FAECES DISCOLOURED 63 0.0029
548 LOSS OF LIBIDO 26 0.0029
549 PROCEDURAL PAIN 80 0.0029
550 RESPIRATORY DISORDER 86 0.0029
551 URINE OUTPUT DECREASED 25 0.0029
552 CONFUSIONAL STATE 462 0.0029
553 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
554 HYPERTENSION 605 0.0029
555 VISION BLURRED 392 0.0029
556 FISTULA 32 0.0028
557 DIZZINESS 1419 0.0028
558 SCRATCH 30 0.0028
559 RHEUMATOID ARTHRITIS 322 0.0028
560 CHOLELITHIASIS 93 0.0028
561 BLOOD PRESSURE DECREASED 188 0.0028
562 ECZEMA 148 0.0028
563 DYSPHAGIA 268 0.0028
564 RASH PRURITIC 153 0.0028
565 EYE SWELLING 105 0.0028
566 PNEUMONIA 908 0.0028
567 PRESYNCOPE 68 0.0028
568 END STAGE RENAL DISEASE 51 0.0028
569 SPINAL FRACTURE 56 0.0028
570 CLOSTRIDIUM DIFFICILE INFECTION 61 0.0028
571 DYSPNOEA 1578 0.0028
572 ANKLE FRACTURE 43 0.0028
573 BLOOD ALBUMIN DECREASED 22 0.0028
574 PANIC ATTACK 101 0.0028
575 SKIN SWELLING 24 0.0028
576 OSTEOMYELITIS 50 0.0028
577 CONDITION AGGRAVATED 839 0.0028
578 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
579 KIDNEY INFECTION 54 0.0027
580 SKIN ULCER 71 0.0027
581 THROAT TIGHTNESS 74 0.0027
582 IMPAIRED DRIVING ABILITY 31 0.0027
583 DEPRESSION 620 0.0027
584 MENTAL IMPAIRMENT 66 0.0027
585 INCREASED APPETITE 52 0.0027
586 DEMENTIA 76 0.0027
587 GINGIVAL BLEEDING 37 0.0027
588 EYE DISORDER 89 0.0027
589 PALPITATIONS 317 0.0027
590 LOWER LIMB FRACTURE 52 0.0027
591 HIP FRACTURE 87 0.0027
592 DRUG EFFECT LESS THAN EXPECTED 40 0.0027
593 THERAPEUTIC RESPONSE UNEXPECTED 121 0.0027
594 BACTERAEMIA 32 0.0027
595 HYPOTHYROIDISM 86 0.0027
596 PRURITUS 1034 0.0027
597 NIGHTMARE 93 0.0027
598 DYSARTHRIA 101 0.0027
599 ASTHMA 303 0.0027
600 LABORATORY TEST ABNORMAL 79 0.0027
601 DEHYDRATION 356 0.0027
602 TRANSIENT ISCHAEMIC ATTACK 90 0.0027
603 PHOTOSENSITIVITY REACTION 44 0.0027
604 DEVICE RELATED INFECTION 41 0.0027
605 ORAL DISCOMFORT 37 0.0027
606 LETHARGY 153 0.0027
607 IMPAIRED GASTRIC EMPTYING 36 0.0026
608 OSTEOPENIA 40 0.0026
609 EATING DISORDER 56 0.0026
610 HALLUCINATION 198 0.0026
611 INFECTION 380 0.0026
612 VERTIGO 160 0.0026
613 INFLUENZA LIKE ILLNESS 216 0.0026
614 RASH 1142 0.0026
615 GROIN PAIN 23 0.0026
616 PULMONARY MASS 39 0.0026
617 HAEMOPTYSIS 73 0.0026
618 MOUTH ULCERATION 55 0.0026
619 UPPER LIMB FRACTURE 52 0.0026
620 ERECTILE DYSFUNCTION 67 0.0026
621 THERAPY NON-RESPONDER 117 0.0026
622 PLATELET COUNT DECREASED 276 0.0026
623 LIMB DISCOMFORT 80 0.0026
624 COLITIS 98 0.0026
625 COORDINATION ABNORMAL 36 0.0026
626 DIPLOPIA 67 0.0026
627 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 464 0.0026
628 VAGINAL DISCHARGE 26 0.0026
629 PULMONARY THROMBOSIS 28 0.0026
630 FLUSHING 261 0.0026
631 ATRIAL FIBRILLATION 250 0.0026
632 NAUSEA 2031 0.0026
633 HYPERSENSITIVITY 475 0.0026
634 PRESCRIBED UNDERDOSE 51 0.0026
635 PULMONARY FIBROSIS 49 0.0026
636 ASCITES 75 0.0025
637 SCHIZOPHRENIA 31 0.0025
638 HEPATOMEGALY 25 0.0025
639 CHEST PAIN 471 0.0025
640 DRY SKIN 338 0.0025
641 HEART RATE DECREASED 88 0.0025
642 GENERALISED OEDEMA 31 0.0025
643 MASS 35 0.0025
644 DISTURBANCE IN ATTENTION 135 0.0025
645 EYE IRRITATION 144 0.0025
646 DEPRESSED MOOD 132 0.0025
647 INTESTINAL OBSTRUCTION 94 0.0025
648 INTENTIONAL PRODUCT MISUSE 218 0.0025
649 RASH MACULAR 87 0.0025
650 APHASIA 75 0.0025
651 COMPLICATION ASSOCIATED WITH DEVICE 36 0.0025
652 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 176 0.0025
653 MITRAL VALVE INCOMPETENCE 28 0.0025
654 PRODUCT USE IN UNAPPROVED INDICATION 613 0.0025
655 BONE DISORDER 45 0.0025
656 APATHY 36 0.0025
657 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
658 CHOLECYSTECTOMY 28 0.0024
659 SOMNOLENCE 493 0.0024
660 PULMONARY HYPERTENSION 51 0.0024
661 SQUAMOUS CELL CARCINOMA 23 0.0024
662 THERAPEUTIC RESPONSE SHORTENED 81 0.0024
663 BREAST PAIN 26 0.0024
664 HAEMOGLOBIN DECREASED 250 0.0024
665 MYOPATHY 21 0.0024
666 ABDOMINAL PAIN 565 0.0024
667 TREMOR 402 0.0024
668 CYST 30 0.0024
669 FEELING JITTERY 46 0.0024
670 EYE INFLAMMATION 23 0.0024
671 DISCOMFORT 147 0.0024
672 CHOKING 47 0.0024
673 ANXIETY 682 0.0024
674 LIVER DISORDER 106 0.0024
675 IMPAIRED WORK ABILITY 51 0.0024
676 EMOTIONAL DISORDER 73 0.0024
677 ROAD TRAFFIC ACCIDENT 99 0.0024
678 CRYING 86 0.0024
679 PRODUCT TASTE ABNORMAL 32 0.0024
680 THROMBOSIS 190 0.0024
681 RENAL DISORDER 110 0.0024
682 GALLBLADDER DISORDER 42 0.0024
683 URTICARIA 394 0.0023
684 HYPOACUSIS 101 0.0023
685 ACCIDENT 28 0.0023
686 BLOOD POTASSIUM INCREASED 38 0.0023
687 OEDEMA PERIPHERAL 284 0.0023
688 VISUAL IMPAIRMENT 288 0.0023
689 IRRITABILITY 139 0.0023
690 VENTRICULAR EXTRASYSTOLES 24 0.0023
691 HAEMORRHOIDS 45 0.0023
692 INJURY 162 0.0023
693 CATARACT 137 0.0023
694 HUNGER 32 0.0023
695 MALAISE 1006 0.0023
696 SPEECH DISORDER 120 0.0023
697 AMNESIA 149 0.0023
698 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
699 INTERNAL HAEMORRHAGE 26 0.0023
700 TENDON RUPTURE 28 0.0023
701 HYPERHIDROSIS 290 0.0022
702 VOMITING 1058 0.0022
703 PROSTATIC SPECIFIC ANTIGEN INCREASED 31 0.0022
704 MATERNAL EXPOSURE DURING PREGNANCY 200 0.0022
705 BLOOD COUNT ABNORMAL 34 0.0022
706 ANAEMIA 427 0.0022
707 ELECTROLYTE IMBALANCE 26 0.0022
708 MOOD SWINGS 71 0.0022
709 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63 0.0022
710 DIABETES MELLITUS 169 0.0022
711 WHITE BLOOD CELL COUNT INCREASED 85 0.0022
712 MUSCLE TWITCHING 51 0.0022
713 LYMPHOCYTE COUNT DECREASED 39 0.0022
714 OFF LABEL USE 1928 0.0022
715 DERMATITIS ATOPIC 116 0.0022
716 SPINAL OPERATION 27 0.0022
717 PAIN OF SKIN 59 0.0022
718 CORONARY ARTERY OCCLUSION 30 0.0022
719 LOSS OF CONSCIOUSNESS 280 0.0022
720 HALLUCINATION, VISUAL 46 0.0022
721 GENERAL PHYSICAL HEALTH DETERIORATION 252 0.0022
722 PHARYNGITIS 27 0.0022
723 TOXICITY TO VARIOUS AGENTS 367 0.0022
724 ATELECTASIS 21 0.0022
725 FOOT FRACTURE 41 0.0022
726 SEIZURE 249 0.0022
727 PLEURAL EFFUSION 131 0.0022
728 SWOLLEN TONGUE 67 0.0021
729 PNEUMOTHORAX 34 0.0021
730 DYSKINESIA 87 0.0021
731 DECREASED IMMUNE RESPONSIVENESS 21 0.0021
732 INJECTION SITE REACTION 147 0.0021
733 SEPSIS 238 0.0021
734 SEXUAL DYSFUNCTION 25 0.0021
735 STAPHYLOCOCCAL INFECTION 70 0.0021
736 CHRONIC KIDNEY DISEASE 161 0.0021
737 CORONARY ARTERY DISEASE 64 0.0021
738 PYREXIA 731 0.0021
739 OESOPHAGITIS 23 0.0021
740 COLD SWEAT 37 0.0021
741 DISORIENTATION 83 0.0021
742 BRAIN INJURY 21 0.0021
743 BLOOD TRIGLYCERIDES INCREASED 37 0.0021
744 HIP ARTHROPLASTY 32 0.0021
745 TOOTH EXTRACTION 26 0.0021
746 MENTAL STATUS CHANGES 58 0.0021
747 SURGERY 122 0.0021
748 DISABILITY 41 0.0021
749 ADRENAL INSUFFICIENCY 25 0.0021
750 GASTRITIS 54 0.0021
751 NERVOUSNESS 107 0.0020
752 SKIN CANCER 44 0.0020
753 INJECTION SITE BRUISING 162 0.0020
754 BLOOD UREA INCREASED 34 0.0020
755 EYE PRURITUS 68 0.0020
756 PETECHIAE 21 0.0020
757 SWELLING FACE 131 0.0020
758 HAIR COLOUR CHANGES 25 0.0020
759 GASTRIC ULCER 38 0.0020
760 ERYTHEMA 410 0.0020
761 HAEMATOCHEZIA 110 0.0020
762 ABNORMAL DREAMS 55 0.0020
763 JOINT DISLOCATION 21 0.0020
764 ANGER 67 0.0020
765 GLAUCOMA 38 0.0020
766 HAEMATURIA 67 0.0020
767 URINARY RETENTION 65 0.0019
768 PERICARDIAL EFFUSION 45 0.0019
769 MULTIPLE SCLEROSIS 93 0.0019
770 RECTAL HAEMORRHAGE 83 0.0019
771 CHOLECYSTITIS 23 0.0019
772 SEROTONIN SYNDROME 37 0.0019
773 MUSCLE RIGIDITY 23 0.0019
774 ACTIVITIES OF DAILY LIVING IMPAIRED 38 0.0019
775 UVEITIS 26 0.0019
776 PNEUMONITIS 52 0.0019
777 SEPTIC SHOCK 83 0.0019
778 COLITIS ULCERATIVE 85 0.0019
779 POST PROCEDURAL HAEMORRHAGE 22 0.0019
780 PRODUCT USE ISSUE 355 0.0019
781 BLOOD CREATININE INCREASED 123 0.0019
782 MOOD ALTERED 51 0.0019
783 CARDIOMEGALY 23 0.0019
784 NEOPLASM PROGRESSION 65 0.0019
785 DELUSION 29 0.0019
786 MALIGNANT MELANOMA 25 0.0019
787 THERAPY PARTIAL RESPONDER 29 0.0019
788 UNEVALUABLE EVENT 140 0.0018
789 ECONOMIC PROBLEM 28 0.0018
790 RASH ERYTHEMATOUS 88 0.0018
791 DRUG ABUSE 153 0.0018
792 DEAFNESS 48 0.0018
793 SUICIDAL IDEATION 168 0.0018
794 FOETAL EXPOSURE DURING PREGNANCY 149 0.0018
795 SYNCOPE 183 0.0018
796 ADVERSE DRUG REACTION 164 0.0018
797 HYPOXIA 64 0.0018
798 PARALYSIS 26 0.0018
799 TREATMENT FAILURE 150 0.0018
800 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
801 WITHDRAWAL SYNDROME 75 0.0018
802 CYANOSIS 28 0.0018
803 HYPONATRAEMIA 100 0.0018
804 HEMIPARESIS 30 0.0018
805 MENTAL DISORDER 77 0.0018
806 LEUKOCYTOSIS 32 0.0018
807 EXPOSURE DURING PREGNANCY 109 0.0018
808 CARDIAC DISORDER 164 0.0018
809 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96 0.0017
810 FEAR 47 0.0017
811 DRUG INTERACTION 277 0.0017
812 ABDOMINAL PAIN LOWER 44 0.0017
813 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0017
814 NERVOUS SYSTEM DISORDER 54 0.0017
815 EYE HAEMORRHAGE 23 0.0017
816 PRODUCT PRESCRIBING ERROR 41 0.0017
817 PULMONARY OEDEMA 77 0.0017
818 NEUTROPHIL COUNT DECREASED 70 0.0017
819 CYTOPENIA 21 0.0017
820 ANGINA PECTORIS 49 0.0017
821 PELVIC PAIN 31 0.0017
822 GLYCOSYLATED HAEMOGLOBIN INCREASED 43 0.0017
823 INJECTION SITE SWELLING 130 0.0017
824 ALANINE AMINOTRANSFERASE INCREASED 104 0.0017
825 CARDIAC FAILURE CONGESTIVE 136 0.0017
826 RENAL FAILURE 224 0.0017
827 UNDERDOSE 123 0.0017
828 LYMPHOMA 26 0.0017
829 PARANOIA 29 0.0017
830 INJECTION SITE DISCOLOURATION 21 0.0017
831 ANHEDONIA 44 0.0017
832 PRESCRIBED OVERDOSE 32 0.0017
833 INJECTION SITE PAIN 507 0.0017
834 INTERSTITIAL LUNG DISEASE 80 0.0017
835 LIP SWELLING 55 0.0016
836 RASH PAPULAR 37 0.0016
837 PSORIASIS 215 0.0016
838 INJECTION SITE PRURITUS 110 0.0016
839 MANIA 27 0.0016
840 RESPIRATORY DISTRESS 45 0.0016
841 COAGULOPATHY 27 0.0016
842 TREATMENT NONCOMPLIANCE 88 0.0016
843 PRODUCT PRESCRIBING ISSUE 35 0.0016
844 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
845 PULMONARY EMBOLISM 152 0.0016
846 APPLICATION SITE PAIN 35 0.0016
847 FEBRILE NEUTROPENIA 105 0.0016
848 HAEMATOMA 41 0.0016
849 HAEMORRHAGE 165 0.0016
850 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
851 JAUNDICE 42 0.0016
852 PHARYNGEAL OEDEMA 24 0.0016
853 THERAPEUTIC RESPONSE DECREASED 94 0.0015
854 FEMUR FRACTURE 48 0.0015
855 DEVICE USE ISSUE 27 0.0015
856 PALLOR 42 0.0015
857 BRONCHOSPASM 22 0.0015
858 PANCYTOPENIA 86 0.0015
859 INJECTION SITE ERYTHEMA 190 0.0015
860 TACHYCARDIA 136 0.0015
861 MUCOSAL INFLAMMATION 40 0.0015
862 MULTIPLE SCLEROSIS RELAPSE 104 0.0015
863 GASTRIC DISORDER 52 0.0015
864 EXPOSURE VIA SKIN CONTACT 39 0.0015
865 PLASMA CELL MYELOMA 58 0.0015
866 LYMPHOPENIA 21 0.0015
867 NEEDLE ISSUE 43 0.0015
868 COLON CANCER 22 0.0015
869 EXPIRED PRODUCT ADMINISTERED 49 0.0015
870 BONE DENSITY DECREASED 46 0.0015
871 DEEP VEIN THROMBOSIS 95 0.0015
872 INJECTION SITE HAEMORRHAGE 116 0.0015
873 BRADYCARDIA 77 0.0015
874 PRODUCT QUALITY ISSUE 196 0.0014
875 PRODUCT PHYSICAL ISSUE 29 0.0014
876 INJECTION SITE RASH 44 0.0014
877 INJECTION SITE MASS 53 0.0014
878 RESTLESSNESS 52 0.0014
879 RENAL IMPAIRMENT 119 0.0014
880 BLOOD GLUCOSE DECREASED 68 0.0014
881 LUNG NEOPLASM MALIGNANT 58 0.0014
882 VAGINAL HAEMORRHAGE 61 0.0014
883 AGITATION 103 0.0014
884 DEVICE ISSUE 124 0.0014
885 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
886 APPLICATION SITE PRURITUS 31 0.0014
887 NEOPLASM MALIGNANT 91 0.0014
888 DISEASE PROGRESSION 161 0.0014
889 DYSTONIA 26 0.0013
890 METASTASES TO BONE 22 0.0013
891 EXTRA DOSE ADMINISTERED 54 0.0013
892 BLOOD BILIRUBIN INCREASED 36 0.0013
893 VENTRICULAR TACHYCARDIA 22 0.0013
894 HOSPITALISATION 204 0.0013
895 PRODUCT PREPARATION ERROR 27 0.0013
896 OVERDOSE 282 0.0013
897 LIVER FUNCTION TEST ABNORMAL 38 0.0013
898 INCORRECT DOSE ADMINISTERED 298 0.0013
899 PRURITUS GENERALISED 28 0.0013
900 ACNE 98 0.0013
901 DELIRIUM 44 0.0013
902 ABNORMAL BEHAVIOUR 50 0.0013
903 ACUTE KIDNEY INJURY 193 0.0013
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 255 0.0013
905 DRUG INEFFECTIVE 1654 0.0013
906 BLINDNESS 51 0.0013
907 PNEUMONIA ASPIRATION 31 0.0012
908 SKIN BURNING SENSATION 87 0.0012
909 HYPOKALAEMIA 56 0.0012
910 BLOOD GLUCOSE INCREASED 228 0.0012
911 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
912 CEREBRAL HAEMORRHAGE 43 0.0012
913 HEPATIC FAILURE 36 0.0012
914 BLOOD GLUCOSE ABNORMAL 22 0.0012
915 APPLICATION SITE ERYTHEMA 31 0.0012
916 ARRHYTHMIA 56 0.0012
917 AGGRESSION 59 0.0012
918 SHOCK 27 0.0012
919 UNRESPONSIVE TO STIMULI 30 0.0012
920 CARDIAC FAILURE 93 0.0012
921 ANAPHYLACTIC REACTION 64 0.0012
922 TOOTH LOSS 24 0.0012
923 DEVICE DISLOCATION 50 0.0011
924 PANCREATITIS 60 0.0011
925 CEREBROVASCULAR ACCIDENT 191 0.0011
926 MALIGNANT NEOPLASM PROGRESSION 114 0.0011
927 PANCREATITIS ACUTE 25 0.0011
928 HYPOCALCAEMIA 21 0.0011
929 PRODUCT COMPLAINT 28 0.0011
930 INJECTION SITE URTICARIA 27 0.0011
931 ABASIA 27 0.0011
932 CARDIAC ARREST 89 0.0011
933 HYPERKALAEMIA 37 0.0011
934 HYPOGLYCAEMIA 51 0.0011
935 SKIN IRRITATION 48 0.0010
936 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
937 INJECTION SITE WARMTH 21 0.0010
938 RESPIRATORY FAILURE 74 0.0010
939 MEDICATION ERROR 56 0.0010
940 ADVERSE EVENT 91 0.0010
941 PSYCHOTIC DISORDER 29 0.0010
942 ENCEPHALOPATHY 24 0.0010
943 RHABDOMYOLYSIS 40 0.0010
944 THROMBOCYTOPENIA 106 0.0009
945 DRUG ADMINISTRATION ERROR 29 0.0009
946 HEPATOTOXICITY 21 0.0009
947 RENAL FAILURE ACUTE 40 0.0009
948 DEVICE MALFUNCTION 65 0.0009
949 NEUTROPENIA 124 0.0009
950 HYPERGLYCAEMIA 33 0.0009
951 OSTEONECROSIS OF JAW 22 0.0009
952 HAEMATEMESIS 22 0.0009
953 MYOCARDIAL INFARCTION 151 0.0009
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 40 0.0009
955 INCORRECT DRUG ADMINISTRATION DURATION 24 0.0009
956 OSTEONECROSIS 28 0.0009
957 METABOLIC ACIDOSIS 27 0.0008
958 VISUAL ACUITY REDUCED 28 0.0008
959 PRODUCT DOSE OMISSION 55 0.0008
960 DRUG EFFECT INCOMPLETE 30 0.0008
961 EMOTIONAL DISTRESS 99 0.0008
962 INCORRECT DOSE ADMINISTERED BY DEVICE 21 0.0008
963 LEUKOPENIA 40 0.0008
964 PREMATURE BABY 24 0.0008
965 ACCIDENTAL OVERDOSE 29 0.0008
966 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
967 DEVICE LEAKAGE 34 0.0008
968 TARDIVE DYSKINESIA 22 0.0008
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55 0.0008
970 DEATH 661 0.0008
971 RESPIRATORY ARREST 21 0.0008
972 DRUG EFFECT DECREASED 41 0.0008
973 ACCIDENTAL EXPOSURE TO PRODUCT 78 0.0008
974 ACUTE MYOCARDIAL INFARCTION 22 0.0007
975 HEPATIC FUNCTION ABNORMAL 25 0.0007
976 DEVICE BREAKAGE 27 0.0007
977 CONVULSION 38 0.0007
978 DRUG DOSE OMISSION 108 0.0007
979 CARDIO-RESPIRATORY ARREST 27 0.0006
980 BREAST CANCER 59 0.0006
981 PRODUCT STORAGE ERROR 55 0.0006
982 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
983 MYELOSUPPRESSION 22 0.0006
984 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
985 DEVICE DIFFICULT TO USE 35 0.0005
986 DRUG WITHDRAWAL SYNDROME 45 0.0005
987 DRUG DEPENDENCE 80 0.0005
988 COMA 21 0.0004
989 NO ADVERSE EVENT 79 0.0004
990 SUICIDE ATTEMPT 26 0.0004
991 PROSTATE CANCER 28 0.0003
992 DRUG DOSE OMISSION BY DEVICE 24 0.0003